PRC200-SS
Подписчиков: 0, рейтинг: 0
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| ECHA InfoCard | 100.207.294 |
| Chemical and physical data | |
| Formula | C20H21NO |
| Molar mass | 291.394 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic.
Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity, precluding any further drug development.
| |||||||||||||||||||||
| |||||||||||||||||||||
|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
DAT (DRIs) |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NET (NRIs) |
|
||||||||||||||
|
SERT (SRIs) |
|
||||||||||||||
| VMATs | |||||||||||||||
| Others |
|
||||||||||||||